We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Samsung

Develops, manufactures, and markets diagnostic products and solutions for IVD and point-of-care applications read more Featured Products: More products

Download Mobile App




Upgraded Diagnostic Ultrasound Features New Deep Learning Algorithm

By HospiMedica International staff writers
Posted on 28 Apr 2016
A global medical equipment company has announced an upgrade for a premium ultrasound imaging system that includes deep learning technology for image analysis of breast lesions.

The goal of the upgraded breast lesion analysis tool is to increase the efficiency of radiologists by providing deep learning algorithm and other imaging enhancements including CEUS (Contrast-enhanced ultrasound) and fusion diagnostic imaging functions.

The Samsung Medison (Seoul, Korea) S-Detect for Breast upgrade for the premium RS80A with Prestige ultrasound system uses big data from many breast exams to provide the characteristics of displayed lesions and an analysis of whether a lesion is malignant or benign. More...
The deep learning algorithm can improve the accuracy of diagnostic image analysis results by providing lesion characteristic analysis, segmentation, and assessment.

The RS80A with Prestige upgrade also includes an improved S-Fusion tool, CEUS+ with VesselMax and FlowMax tools for vessel and blood flow visualization, S-3D arterial analysis for 3-D vessel imaging and simplified artery plaque volume. The upgrade also includes improved near-to-far-field image conformity and reduced signal noise using advanced S-Harmonic technology. The HQ Vision tool enables improved visualization of anatomical structures, increases the reliability of diagnosis for musculoskeletal, and other imaging types.

The new RS80A with Prestige upgrade is currently available in Europe, and the Middle East, and will be launched in China, Russia, and the Americas at a later date.

Professor Han Boo Kyung, radiologist, Samsung Medical Center, said, "We saw a high level of conformity from analyzing and detecting lesion in various cases by using the S-Detect. Users can reduce taking unnecessary biopsies and doctors-in-training will likely have more reliable support in accurately detecting malignant and suspicious lesions."

Related Links:
Samsung Medison


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Fetal Monitor
BT-380
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.